EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Evaluating Hunger Manipulation During Feeding Intervention

Not Applicable

Completed

Conditions: Avoidant/Restrictive Food Intake Disorder
Feeding Disorders
Feeding and Eating Disorders

Interventions: Behavioral: Intensive Multidisciplinary Feeding Intervention (IMFI) standard of care + rapid tube weaning
Behavioral: Intensive Multidisciplinary Feeding Intervention (IMFI)-Standard of Care

First Posted Date: 2021-09-22

Last Posted Date: 2023-11-28

Lead Sponsor: Emory University

Target Recruit Count: 16

Registration Number: NCT05053438

Locations: 🇺🇸
Center for Advanced Pediatrics, Atlanta, Georgia, United States
🇺🇸
Marcus Autism Center, Atlanta, Georgia, United States

Brentuximab Vedotin and Nivolumab for the Treatment of Relapsed/Refractory Classic Hodgkin Lymphoma Previously Treated With Brentuximab Vedotin or Checkpoint Inhibitors

Phase 2

Recruiting

Conditions: Refractory Classic Hodgkin Lymphoma
Recurrent Classic Hodgkin Lymphoma

Interventions: Drug: Brentuximab Vedotin
Procedure: Hematopoietic Cell Transplantation
Biological: Nivolumab
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2021-09-09

Last Posted Date: 2024-07-15

Lead Sponsor: Emory University

Target Recruit Count: 46

Registration Number: NCT05039073

Locations: 🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States

Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma

Phase 1

Recruiting

Conditions: Asthma

Interventions: Drug: Albuterol Sulfate
Drug: Interferon gamma-primed mesenchymal stromal cells (MSCs)
Drug: Prednisone

First Posted Date: 2021-09-05

Last Posted Date: 2023-08-24

Lead Sponsor: Emory University

Target Recruit Count: 12

Registration Number: NCT05035862

Locations: 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States

Multisite Observational Maternal and Infant Study for COVID-19

Completed

Conditions: COVID-19

Interventions: Biological: Licensed or EUA SARS-CoV-2 vaccine

First Posted Date: 2021-09-02

Last Posted Date: 2024-06-27

Lead Sponsor: Emory University

Target Recruit Count: 562

Registration Number: NCT05031468

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States
🇺🇸
Seattle Children's Hospital, Seattle, Washington, United States

and more 7 locations

Assessing Durable Antibody Response to HPV Vaccination

Phase 4

Recruiting

Conditions: HPV

Interventions: Biological: Gardasil
Drug: Lidocaine injections

First Posted Date: 2021-09-01

Last Posted Date: 2024-02-28

Lead Sponsor: Emory University

Target Recruit Count: 50

Registration Number: NCT05031078

Locations: 🇺🇸
The Hope Clinic of Emory University, Atlanta, Georgia, United States
🇺🇸
Winship Cancer Institute, Atlanta, Georgia, United States

BEFAST (Bubble-Enhanced FAST) for the Evaluation of Solid Organ Injury

Phase 4

Completed

Conditions: Abdominal Trauma

Interventions: Diagnostic Test: Focused Assessment with Sonography for Trauma (FAST)
Drug: Bubble-Enhanced FAST (BEFAST)

First Posted Date: 2021-08-27

Last Posted Date: 2024-10-08

Lead Sponsor: Emory University

Target Recruit Count: 267

Registration Number: NCT05025449

Locations: 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States

Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma

Early Phase 1

Withdrawn

Conditions: Recurrent Gliosarcoma
Recurrent Glioblastoma

Interventions: Drug: Liothyronine
Drug: Lomustine
Drug: Methimazole

First Posted Date: 2021-08-24

Last Posted Date: 2022-12-02

Lead Sponsor: Emory University

Registration Number: NCT05017610

Caregiver Adverse Childhood Experiences (ACEs) in Pediatric Primary Care

Not Applicable

Active, not recruiting

Conditions: Child Development

Interventions: Behavioral: Training on study procedures
Behavioral: Training for ACEs and study procedures

First Posted Date: 2021-08-19

Last Posted Date: 2024-10-15

Lead Sponsor: Emory University

Target Recruit Count: 181

Registration Number: NCT05013138

Locations: 🇺🇸
Mercy Care Chamblee, Chamblee, Georgia, United States

Well-child Visit Video Project

Not Applicable

Completed

Conditions: Type 2 Diabetes

Interventions: Behavioral: Educational Video about SCB
Behavioral: Survey on child feeding and related knowledge and practices
Behavioral: Educational Video other than SCB

First Posted Date: 2021-08-18

Last Posted Date: 2024-06-20

Lead Sponsor: Emory University

Target Recruit Count: 388

Registration Number: NCT05011292

Locations: 🇺🇸
Children's Healthcare of Atlanta - Hughes Spalding Hospital, Atlanta, Georgia, United States

Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy

Not Applicable

Recruiting

Conditions: Cerebral Palsy

Interventions: Behavioral: Standard of Care
Other: APPLES-tele
Behavioral: Parent-centered Approach (PCA) Support Intervention

First Posted Date: 2021-08-09

Last Posted Date: 2023-08-30

Lead Sponsor: Emory University

Target Recruit Count: 267

Registration Number: NCT04997109

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
Kennedy Krieger Institute, Baltimore, Maryland, United States
🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

and more 1 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy